Changchun Shao

540 total citations
12 papers, 383 citations indexed

About

Changchun Shao is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Changchun Shao has authored 12 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Changchun Shao's work include MicroRNA in disease regulation (4 papers), Liver physiology and pathology (3 papers) and Cancer Mechanisms and Therapy (2 papers). Changchun Shao is often cited by papers focused on MicroRNA in disease regulation (4 papers), Liver physiology and pathology (3 papers) and Cancer Mechanisms and Therapy (2 papers). Changchun Shao collaborates with scholars based in China and Netherlands. Changchun Shao's co-authors include Guo‐Jun Zhang, Xiaolong Wei, Wen-Jia Chen, Jun Feng, Xing Zhao, Jianzhen Xu, Hongyan Dong, Fan Zhang, Xiaojia Wang and Qian Ying and has published in prestigious journals such as Cancer Letters, Cell Death and Disease and Frontiers in Oncology.

In The Last Decade

Changchun Shao

11 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Changchun Shao China	8	298	271	42	33	20	12	383
Hong-Liang Zang China	10	262 0.9×	227 0.8×	45 1.1×	31 0.9×	44 2.2×	16	344
Feiye Liu China	9	213 0.7×	148 0.5×	19 0.5×	44 1.3×	29 1.4×	13	294
Zixi Liang China	7	304 1.0×	218 0.8×	26 0.6×	93 2.8×	19 0.9×	15	412
Xudan Wang China	8	204 0.7×	167 0.6×	30 0.7×	37 1.1×	23 1.1×	13	316
Shoumei Yang China	6	225 0.8×	172 0.6×	17 0.4×	48 1.5×	25 1.3×	8	296
Liyuan Qian China	5	192 0.6×	165 0.6×	32 0.8×	57 1.7×	24 1.2×	9	267
Mengxue Sun China	7	257 0.9×	170 0.6×	81 1.9×	60 1.8×	20 1.0×	19	355
Yeun-po Chiang China	9	270 0.9×	229 0.8×	13 0.3×	31 0.9×	28 1.4×	13	352
Luyuan Ma China	8	188 0.6×	159 0.6×	22 0.5×	50 1.5×	31 1.6×	17	261

Countries citing papers authored by Changchun Shao

Since Specialization

Citations

This map shows the geographic impact of Changchun Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changchun Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changchun Shao more than expected).

Fields of papers citing papers by Changchun Shao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changchun Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changchun Shao. The network helps show where Changchun Shao may publish in the future.

Co-authorship network of co-authors of Changchun Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Changchun Shao. A scholar is included among the top collaborators of Changchun Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changchun Shao. Changchun Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ma, Wenwen, Han‐Qing Yu, Lulu Fan, et al.. (2025). Efficacy and safety of camrelizumab in combination with S-1 plus oxaliplatin sequenced by camrelizumab-based maintenance therapy as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study. Journal of Gastrointestinal Oncology. 16(2). 342–353.

Hou, Xiaojuan, Luyao Zhang, Luyao Zhang, et al.. (2022). 3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages. Frontiers in Oncology. 12. 877982–877982. 5 indexed citations

Hou, Xiaojuan, Wenting Liu, Xue Yang, et al.. (2022). Extracellular microparticles derived from hepatic progenitor cells deliver a death signal to hepatoma-initiating cells. Journal of Nanobiotechnology. 20(1). 79–79. 2 indexed citations

Shao, Changchun, Yingying Jing, Shanmin Zhao, et al.. (2022). LPS/Bcl3/YAP1 signaling promotes Sox9+HNF4α+ hepatocyte-mediated liver regeneration after hepatectomy. Cell Death and Disease. 13(3). 277–277. 11 indexed citations

Tian, Zhiqiang, Xiaojuan Hou, Wenting Liu, et al.. (2022). Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of hepatocarcinoma. Cancer Cell International. 22(1). 362–362. 7 indexed citations

Hou, Xiaojuan, Changchun Shao, Kai Sun, et al.. (2021). Autophagy deficiency downregulates O6methylguanine-DNA methyltransferase and increases chemosensitivity of liver cancer cells. Aging. 13(10). 14289–14303. 3 indexed citations

Huang, Yihua, Xue Yang, Yan Meng, et al.. (2021). The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages. Cell & Bioscience. 11(1). 173–173. 39 indexed citations

Yang, Xue, Changchun Shao, Lixia Duan, et al.. (2021). Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α. Cancer Letters. 517. 46–54. 26 indexed citations

Shao, Changchun, Xue Yang, Yingying Jing, et al.. (2021). The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation. Stem Cell Research & Therapy. 12(1). 342–342. 7 indexed citations

10.

Cai, Yujie, Xing Zhao, Fan Zhang, et al.. (2021). circ-NOL10 regulated by MTDH/CASC3 inhibits breast cancer progression and metastasis via multiple miRNAs and PDCD4. Molecular Therapy — Nucleic Acids. 26. 773–786. 16 indexed citations

11.

Xu, Jianzhen, Changchun Shao, Xiaojia Wang, et al.. (2019). circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death and Disease. 10(3). 175–175. 205 indexed citations

12.

Li, Ronghui, Min Chen, Jing Liu, et al.. (2018). Long noncoding RNA ATB promotes the epithelial−mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer. Cell Death and Disease. 9(12). 1171–1171. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact